Mukka Proteins, a manufacturer of fishmeal, fish oil, and fish-soluble paste, is making waves with its upcoming IPO. Mukka Proteins is a 21-year-old company which also exports its fish-based protein products to over ten countries. While the Mukka Proteins IPO may sound like a compelling opportunity for an IPO investment, let us look at the fundamentals and financials of the company before you decide whether you should invest in the IPO.
Mukka Proteins IPO: highlights
- Growing Industry: The aquaculture and pet food industries, which rely heavily on Mukka's products, are experiencing significant growth. This could translate to increased demand for the company's offerings.
- Global Reach: Mukka exports to over 10 countries, diversifying its revenue streams and mitigating market risks.
- Financial Performance: Revenue and PAT have seen impressive growth in recent years, indicating strong financial health.
- Fresh Issue: The entire IPO proceeds will be used for expansion and working capital, potentially fueling future growth.
Mukka Proteins IPO: fundamentals
- The issue of Mukka Proteins IPO is ₹224 crores with a fresh issue of 8 crore shares.
- The price band of the Mukka Proteins IPO is set at ₹26 to ₹28 per share.
- Mukka Proteins IPO opens for subscription on February 29th, 2024 and will close on March 04th, 2024.
- The lot size for Mukka Proteins IPO is 535 shares.
- Profitability: The PAT has grown 84.07% driven by a revenue growth of 52.52%.
- In addition to four production facilities in India, Mukka Proteins also has two product facilities in Oman, held by its foreign subsidiary, Ocean Aquatic Proteins LLC.
Should you invest in the Mukka Proteins IPO?
Carefully consider your risk tolerance and investment goals before making a decision. Here are some additional factors to weigh.
- Industry outlook: Research the future prospects of the aquaculture and pet food industries to assess their impact on Mukka's demand.
- Competitive Landscape: The fishmeal industry is competitive, with established players and new entrants vying for market share.
- Comparative analysis: Compare Mukka's financials and valuation to its competitors to see how it stacks up.
- Dependence on Third-Party Facilities: Relying on external manufacturers comes with inherent risks, such as quality control and potential supply disruptions.
- Expert opinions: Read analyst reports and market commentaries to gain insights from industry professionals.
Remember
Investing in an IPO carries inherent risks. Conduct thorough due diligence, understand the company's business model and financials, and consult a financial advisor before making any investment decisions.
